These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 3095422)

  • 21. Role of dendritic cells in the regulation of class I restricted cytotoxic T lymphocyte responses.
    Boog CJ; Boes J; Melief CJ
    J Immunol; 1988 May; 140(10):3331-7. PubMed ID: 2452183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L3T4+ cytotoxic T lymphocytes specific for class I H-2 antigens are activated in primary mixed lymphocyte reactions.
    Macphail S; Stutman O
    J Immunol; 1987 Dec; 139(12):4007-15. PubMed ID: 2961804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
    Mizuochi T; Ono S; Malek TR; Singer A
    J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity and frequency of primary anti-HLA cytotoxic T lymphocytes in normal and HLA-B27.2-, HLA-B27.5-, and HLA-Cw3-transgenic mice. A transgenic model for MHC xenoantigen recognition.
    Kievits F; Boerenkamp WJ; Lokhorst W; Ivanyi P
    J Immunol; 1990 Jun; 144(12):4513-9. PubMed ID: 2351823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
    Aosai F; Ohlen C; Ljunggren HG; Höglund P; Franksson L; Ploegh H; Townsend A; Kärre K; Stauss HJ
    Eur J Immunol; 1991 Nov; 21(11):2767-74. PubMed ID: 1936122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse alloantibodies capable of blocking cytotoxic T cell function. V. The majority of I region-specific CTL are Lyt-2+ but are relatively resistant to anti-Lyt-2 blocking.
    Shinohara N; Kojima M
    J Immunol; 1984 Feb; 132(2):578-83. PubMed ID: 6197465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction and activity of class II-restricted, Lyt-2+ cytolytic T lymphocytes specific for the influenza H5 hemagglutinin.
    Hioe CE; Hinshaw VS
    J Immunol; 1989 Apr; 142(7):2482-8. PubMed ID: 2466897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific suppression of antibody responses by soluble protein-specific, class II-restricted cytolytic T lymphocyte clones.
    Shinohara N; Huang YY; Muroyama A
    Eur J Immunol; 1991 Jan; 21(1):23-7. PubMed ID: 1991488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and stimulatory cell type requirements for inducing class I major histocompatibility complex alloantigen-specific in vivo cytotoxic T cell immunity.
    Mizoguchi K; Nakashima I; Isobe K; Ando K; Nagase F; Kato N; Kawashima K; Shimokata K; Hasegawa Y
    Eur J Immunol; 1985 May; 15(5):487-94. PubMed ID: 3873341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Features of target cell lysis by class I and class II MHC-restricted cytolytic T lymphocytes.
    Maimone MM; Morrison LA; Braciale VL; Braciale TJ
    J Immunol; 1986 Dec; 137(11):3639-43. PubMed ID: 3491143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular requirements for the generation of primary cell-mediated lympholysis responses to Qa-1 antigens.
    Huston DP; Jenkins RN; Gresens SE; Smith R; Rich RR
    J Immunol; 1985 Apr; 134(4):2198-204. PubMed ID: 3156180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
    Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
    J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
    Bonavida B; Katz J
    J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic T cells directed against HLA-DR antigens and their surface proteins.
    Burakoff SJ; Clayberger C; Hemler M; Krensky AM; Reiss CS; Robbins E; Sanchez-Madrid F; Springer TA; Strominger JL; Ware CF
    Diagn Immunol; 1983; 1(3):116-9. PubMed ID: 6238749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OKT4+ cytotoxic T cells can lyse targets via class I molecules and can be blocked by monoclonal antibody against T4 molecules.
    Strassman G; Bach FH
    J Immunol; 1984 Oct; 133(4):1705-9. PubMed ID: 6332131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role for helper cell subpopulations in a genetically controlled cytolytic T lymphocyte response to the H-2Db antigen.
    French DL; Plate JM
    J Immunol; 1985 Jul; 135(1):39-46. PubMed ID: 3158704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of antibodies to Lyt-2 and L3T4 on cytolysis by cloned, Ia-restricted T cells expressing both proteins.
    Jones B; Khavari PA; Conrad PJ; Janeway CA
    J Immunol; 1987 Jul; 139(2):380-4. PubMed ID: 3110269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of in vitro cytotoxic T lymphocyte generation. III. Interactions or regulatory T cell subsets in suppressor and target populations.
    Schwartz A; Gershon RK
    J Mol Cell Immunol; 1984; 1(4):237-52. PubMed ID: 6152894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH; Heagy W; Martz E
    J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.